A AddLife AB
A
Geschlossen
151.6 -1.75
Übersicht
Veränderung der Aktienkurses
24h
Min
150.6
Max
154.3
Einkommen | -31M 229M |
|---|---|
Verkäufe | -88M 2.6B |
KGV Branchendurchschnitt | 31.72 91.791 |
EPS | 1.04 |
Dividendenrendite | 1.05 |
Gewinnspanne | 8.658 |
Angestellte | 2,295 |
EBITDA | -373M 229M |
Dividendenrendite Branchendurchschnitt | 1.05% 2.61% |
|---|
Marktkapitalisierung | 390M 18B |
|---|---|
Vorheriger Eröffnungskurs | 153.35 |
Vorheriger Schlusskurs | 151.6 |
AddLife AB Chart
Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.
Ähnliche Nachrichten
Peer-Vergleich
Kursveränderung
AddLife AB Prognose
Finanzen
Vertriebs- und Verwaltungskosten
Betriebsaufwand
Gewinn vor Steuern
Verkäufe
Umsatzkosten
Bruttogewinn aus dem Verkauf
Zinsaufwand für Schulden
EBITDA
Betriebsergebnis
$
Über AddLife AB
AddLife AB (publ), together with its subsidiaries, provides equipment, consumables, and reagents primarily to healthcare sector, research, colleges, and universities, as well as the food and pharmaceutical industries. The company operates through Labtech and Medtech segments. The Labtech segment offers products, solutions, and services in the areas of diagnostics, and biomedical research and laboratory equipment for plastic consumables, cell biology, reagents, lab, and other instruments. The Medtech segment provides medical device products for surgery, thoracic medicine, neurology, wound care, anaesthesia, intensive care, ear, nose and throat, ostomies, and home healthcare, as well as assistive technology for senior citizens and disabled children. It operates in Sweden, the United Kingdom, Ireland, Spain, Denmark, Norway, Italy, Finland, Switzerland, Germany, rest of Europe, and internationally. AddLife AB (publ) was founded in 1906 and is based in Stockholm, Sweden.
